We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
GL Gains From Premium Growth, AI Adoption and Higher Investment Income
Read MoreHide Full Article
Key Takeaways
Globe Life expects 2026 premium growth of 6.5-7%, with health premiums projected to rise 14-16%.
GL expects 7% excess investment income growth, while AI adoption could improve efficiency and lower costs.
Globe Life targets $670-$700 million in 2026 buybacks, supported by its solid capital position.
Globe Life Inc. (GL - Free Report) continues to strengthen its growth outlook through a combination of premium expansion, technology adoption, distribution investments, rising investment income and shareholder-friendly capital deployment. The company’s diversified product portfolio and multiple distribution channels position it to capture opportunities across life and supplemental health markets.
Globe Life’s product mix supports premium expansion across life and supplemental health insurance. Management expects 2026 total premium revenue to increase 6.5-7%, with health premiums projected to grow 14-16%. Medicare Supplement rate increases, and stronger sales at United American and Family Heritage are supporting health growth. Approximately $65 million of additional 2026 premium is expected from approved rate increases on individual Medicare Supplement policies.
Globe Life’s investment spread remains a contributor to earnings growth. For full-year 2026, management expects net investment income and required interest to each grow around 4%, resulting in approximately 7% growth in excess investment income. Expected fixed-maturity reinvestment yields of 6% to 6.1% should support investment spreads.
Technology investments could further enhance profitability. Globe Life is expanding artificial intelligence across applications, customer service and claims processing. Broader AI adoption is expected to improve underwriting, sales productivity and customer engagement while gradually lowering administrative costs.
Globe Life continues to invest in agent recruiting, retention and middle-management development across its exclusive agencies. Management expects mid-single-digit growth in agent count and life sales at American Income in the second half. Liberty National and Family Heritage also posted agent-count growth, supporting future premium generation.
Globe Life’s solid capital position enables meaningful shareholder returns. The company repurchased 1.1 million shares for $175 million in the second quarter and expects 2026 buybacks of $670-$700 million, alongside approximately $95 million of dividends.
Risks for GL
Inflation, economic uncertainty and weaker consumer confidence could pressure Globe Life’s policy sales, premium growth and persistency.
Declining agent counts and lower life sales at American Income and Direct to Consumer highlight recruiting, retention and digital marketing challenges that could constrain future growth.
Regulatory changes, litigation and volatile health claims could pressure GL’s profitability. Higher health obligation ratios and uncertainty around claims experience add further underwriting risks.
NMI Holdings’ earnings surpassed estimates in three of the last four quarters and matched in one, the average surprise being 3.82%.
NMI Holdings is well-poised for growth on new primary insurance written, direct primary insurance in force, and a better risk-based capital ratio. Its mortgage insurance portfolio is expected to create a strong foundation for future earnings. The mortgage insurer should continue to gain from a strong mortgage origination market and increased private mortgage insurance penetration rates.
Palomar’s earnings surpassed estimates in each of the last four quarters, the average surprise being 13.04%.
Palomar is poised to gain from the increased volume of policies written across the lines of business, strong retention rates, strategic expansion of products’ geographic and distribution footprint, and new partnerships. PLMR should benefit from its solid product portfolio as well as geographic expansion and rate increases. Net investment income is expected to grow on the back of a higher average balance of investments. PLMR increased the adjusted net income guidance from $262-$ 278 million to $270-$280 million.
Arch Capital’s earnings surpassed estimates in each of the last four quarters, the average surprise being 12.75%.
Arch Capital boasts a strong product portfolio and has a solid track record of premium growth. Premiums should benefit from new business opportunities, rate increases, growth in existing accounts and growth in Australian single-premium mortgage insurance. A solid capital position shields it from market volatility.
View the Zacks #1 Rank List
Image: Bigstock
GL Gains From Premium Growth, AI Adoption and Higher Investment Income
Key Takeaways
Globe Life Inc. (GL - Free Report) continues to strengthen its growth outlook through a combination of premium expansion, technology adoption, distribution investments, rising investment income and shareholder-friendly capital deployment. The company’s diversified product portfolio and multiple distribution channels position it to capture opportunities across life and supplemental health markets.
Globe Life’s product mix supports premium expansion across life and supplemental health insurance. Management expects 2026 total premium revenue to increase 6.5-7%, with health premiums projected to grow 14-16%. Medicare Supplement rate increases, and stronger sales at United American and Family Heritage are supporting health growth. Approximately $65 million of additional 2026 premium is expected from approved rate increases on individual Medicare Supplement policies.
Globe Life’s investment spread remains a contributor to earnings growth. For full-year 2026, management expects net investment income and required interest to each grow around 4%, resulting in approximately 7% growth in excess investment income. Expected fixed-maturity reinvestment yields of 6% to 6.1% should support investment spreads.
Technology investments could further enhance profitability. Globe Life is expanding artificial intelligence across applications, customer service and claims processing. Broader AI adoption is expected to improve underwriting, sales productivity and customer engagement while gradually lowering administrative costs.
Globe Life continues to invest in agent recruiting, retention and middle-management development across its exclusive agencies. Management expects mid-single-digit growth in agent count and life sales at American Income in the second half. Liberty National and Family Heritage also posted agent-count growth, supporting future premium generation.
Globe Life’s solid capital position enables meaningful shareholder returns. The company repurchased 1.1 million shares for $175 million in the second quarter and expects 2026 buybacks of $670-$700 million, alongside approximately $95 million of dividends.
Risks for GL
Inflation, economic uncertainty and weaker consumer confidence could pressure Globe Life’s policy sales, premium growth and persistency.
Declining agent counts and lower life sales at American Income and Direct to Consumer highlight recruiting, retention and digital marketing challenges that could constrain future growth.
Regulatory changes, litigation and volatile health claims could pressure GL’s profitability. Higher health obligation ratios and uncertainty around claims experience add further underwriting risks.
Other Industry Players
Other industry players include NMI Holdings Inc. (NMIH - Free Report) , Palomar Holdings, Inc. (PLMR - Free Report) and Arch Capital Group Ltd. (ACGL - Free Report) .
NMI Holdings’ earnings surpassed estimates in three of the last four quarters and matched in one, the average surprise being 3.82%.
NMI Holdings is well-poised for growth on new primary insurance written, direct primary insurance in force, and a better risk-based capital ratio. Its mortgage insurance portfolio is expected to create a strong foundation for future earnings. The mortgage insurer should continue to gain from a strong mortgage origination market and increased private mortgage insurance penetration rates.
Palomar’s earnings surpassed estimates in each of the last four quarters, the average surprise being 13.04%.
Palomar is poised to gain from the increased volume of policies written across the lines of business, strong retention rates, strategic expansion of products’ geographic and distribution footprint, and new partnerships. PLMR should benefit from its solid product portfolio as well as geographic expansion and rate increases. Net investment income is expected to grow on the back of a higher average balance of investments. PLMR increased the adjusted net income guidance from $262-$ 278 million to $270-$280 million.
Arch Capital’s earnings surpassed estimates in each of the last four quarters, the average surprise being 12.75%.
Arch Capital boasts a strong product portfolio and has a solid track record of premium growth. Premiums should benefit from new business opportunities, rate increases, growth in existing accounts and growth in Australian single-premium mortgage insurance. A solid capital position shields it from market volatility.